Litigation Details for Gilead Sciences, Inc. v. Laurus Labs Ltd. (D. Del. 2018)
✉ Email this page to a colleague
Gilead Sciences, Inc. v. Laurus Labs Ltd. (D. Del. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-11-06 |
Court | District Court, D. Delaware | Date Terminated | 2018-11-15 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 6,642,245; 6,703,396; 8,592,397; 8,716,264; 9,457,036; 9,744,181 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Gilead Sciences, Inc. v. Laurus Labs Ltd.
Biologic Drugs cited in Gilead Sciences, Inc. v. Laurus Labs Ltd.
Details for Gilead Sciences, Inc. v. Laurus Labs Ltd. (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2018-11-05 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,642,245 B1 ;US 6,703,396 … 15 November 2018 1:18-cv-01748 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
2018-11-14 | 8 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,642,245 B1; US 6,703,396 … 15 November 2018 1:18-cv-01748 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |